These results further confirmed that 4EBP1 might act as an adverse prognostic biomarker for BLCA, BRCA, KIRC, KIRP, and MESO because the increased expression of 4EBP1 was related to both the staging and prognosis of these tumors. The gene discussed is EIF4EBP1; the disease is bladder transitional cell carcinoma.